Behind the Intelligence

Architects of Precision

Bridging the gap between biological complexity and clinical clarity through explainable, decision-grade AI.

Our Foundation

The Aveiaa Philosophy

Founded in 2025, Aveiaa is a drug discovery and development intelligence company with operations in Amman, Jordan and Delaware, USA.

We build decision-grade platforms that help researchers predict development outcomes, reduce risk, and translate scientific complexity into actionable strategy.

  • Predict development outcomes with precision
  • Reduce clinical and innovation risks through explainable reasoning
  • Translate scientific complexity into actionable strategy
  • High-fidelity biological simulations grounded in evidence

Our systems support earlier risk detection, clearer rationale, and faster iteration across the entire R&D lifecycle.

logo aveiaa
The Origin

Inspired by Afiya (عافية)

The origin of our vision is deeply inspired by Afiya, a term synonymous with health and profound well-being. We chose this name intentionally to reflect both our cultural roots and our global ambition as a company built in the region but operating for the world. Through transparency, we pioneer explainable AI where every clinical insight follows a clear causal path to ensure total interpretability for medical experts. By establishing a unified logic, we break down data silos—merging genomics, imaging, and biomarkers into a single high-fidelity source of truth. Ultimately, we deliver decision-grade intelligence where our AI provides deep reasoning rather than just predictions, enabling strategic decisions across the entire spectrum of discovery and development.

What We Build

Turning Evidence into Intelligence

Our mission is to help the world develop superior therapies by transforming complex biomedical evidence into a unified system of explainable intelligence. This journey begins with our Core Databases, which provide clean and structured data layers across chemistry, biology, and clinical evidence. We then elevate this data into Causal Knowledge, creating evidence-linked layers designed to support justified conclusions and strategic clinical insights. Ultimately, this powers our comprehensive Intelligence System, which models development feasibility across efficacy, safety, and clinical outcomes to ensure every discovery reaches its full potential.